Latest debt-to-equity ratio
ArriVent BioPharma Debt-to-equity ratio
Direct answer
ArriVent BioPharma's debt-to-equity ratio is 0.1%.
The verified market snapshot reports 0.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free ArriVent BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.1%
Explore related company data
View ArriVent BioPharma's market capitalizationView ArriVent BioPharma's price-to-book ratioView ArriVent BioPharma's return on equityView ArriVent BioPharma's dividend yieldView ArriVent BioPharma's 52-week price rangeView ArriVent BioPharma's profit marginView all ArriVent BioPharma key metricsReturn to ArriVent BioPharma profile